Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Boyd

Showing results (591-600 of 602) with videos related to

Pageof 61
Sort By:
The Journal of Liquid Biopsy|March 3, 2025
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-<i>nab</i>-paclitaxel in advanced pancreatic cancerLenka N C Boyd, Mahsoem Ali, Jisce R Puik, et al.
Frontiers in Pharmacology|November 3, 2023
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N C Boyd, Lynn E Nooijen, Mahsoem Ali, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Biochemical Pharmacology|January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapyDaniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Gene Therapy|April 23, 2011
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lungG McLachlan, H Davidson, E Holder, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Impacts of fire and prospects for recovery in a tropical peat forest ecosystemMark E Harrison, Nicolas J Deere, Muhammad Ali Imron, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 18, 2023
Editorial Statement About <i>JCCAP</i>'s 2023 Special Issue on Informant Discrepancies in Youth Mental Health Assessments: Observations, Guidelines, and Future Directions Grounded in 60 Years of ResearchAndres De Los Reyes, Catherine C Epkins, Gordon J G Asmundson, et al.
Physical Review Letters|June 21, 2001
Constraints on neutrino oscillations using 1258 days of Super-Kamiokande solar neutrino dataS Fukuda, Y Fukuda, M Ishitsuka, et al.
Physical Review Letters|June 21, 2001
Solar 8B and hep neutrino measurements from 1258 days of Super-Kamiokande dataS Fukuda, Y Fukuda, M Ishitsuka, et al.
Pageof 61

Showing results (591-600 of 602) with videos related to

Sort By:
Pageof 61
The Journal of Liquid Biopsy|March 3, 2025
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-<i>nab</i>-paclitaxel in advanced pancreatic cancerLenka N C Boyd, Mahsoem Ali, Jisce R Puik, et al.
Frontiers in Pharmacology|November 3, 2023
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N C Boyd, Lynn E Nooijen, Mahsoem Ali, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Biochemical Pharmacology|January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapyDaniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Gene Therapy|April 23, 2011
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lungG McLachlan, H Davidson, E Holder, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Impacts of fire and prospects for recovery in a tropical peat forest ecosystemMark E Harrison, Nicolas J Deere, Muhammad Ali Imron, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 18, 2023
Editorial Statement About <i>JCCAP</i>'s 2023 Special Issue on Informant Discrepancies in Youth Mental Health Assessments: Observations, Guidelines, and Future Directions Grounded in 60 Years of ResearchAndres De Los Reyes, Catherine C Epkins, Gordon J G Asmundson, et al.
Physical Review Letters|June 21, 2001
Constraints on neutrino oscillations using 1258 days of Super-Kamiokande solar neutrino dataS Fukuda, Y Fukuda, M Ishitsuka, et al.
Physical Review Letters|June 21, 2001
Solar 8B and hep neutrino measurements from 1258 days of Super-Kamiokande dataS Fukuda, Y Fukuda, M Ishitsuka, et al.
Pageof 61